日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

胰腺癌早期诊断、预防和治疗的进展:过去、现在和未来

Mannucci, Alessandro; Goel, Ajay

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

撤稿声明:BICC1通过诱导不依赖于VEGF的血管生成来驱动胰腺癌进展。

Huang, Chongbiao; Li, Hui; Xu, Yang; Xu, Chao; Sun, Huizhi; Li, Zengxun; Ge, Yi; Wang, Hongwei; Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Yang, Shengyu; Sun, Peiqing; Liu, Zhe; Liu, Jing; Chang, Antao; Hao, Jihui

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

靶向损伤相关巨噬细胞中的GPR34可增强抗肿瘤免疫力并提高苏鲁替尼在胰腺癌中的疗效

Guo, Xiaofan; Liu, Yuxiao; Li, Tianchen; An, Xiaopeng; Song, Yuning; Xu, Peijun; Huang, Jing; Zou, Yiping; Xu, Bohang; Xie, Yongjie; Li, Zekun; Meng, Chenyang; Zhao, Tiansuo; Wang, Xiuchao; Wang, Hongwei; Gao, Chuntao; Zhou, Xuan; Yu, Jun; Gao, Song; Hao, Jihui

Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis

代谢功能障碍相关的脂肪肝疾病通过巨噬细胞迁移抑制因子-CD44轴加速胰腺癌的进展和转移。

Yu, Qian; Song, Hui; Shi, Xiao-Ya; Zhu, Liang; Liang, Yu; Gong, Rui-Ning; Dong, Xiao-Wu; Liu, Shang-Long; Wang, Hai-Zhen; Wang, Ying-Luo; Cui, Jiu-Fa; Yang, Xiao-Nan; Chen, Ying; Gao, Chao; Yang, Zhan; Zhu, Qing-Tian; Li, Chang; Zhang, Huan; Ying, Jie-Er; Zheng, Mei-Fang; Tian, Yan-Tao; Hu, Hai-Tao; Shao, Xin-Xin; Li, Yue; Mo, Ming-Guang; Lu, Yun; Ma, Zheng; Fu, Shun-Li; Niu, Qing-Hui; Liao, Yuan-Yu; Zhao, Chen-Yang; Liu, Xin; Saluja, Ashok K; Wang, Ji-Gang; Li, Xiao-Yu; Guo, Song-Yue; Wang, Wei-Hua; Wang, Song; Liu, Bin; Lu, Guo-Tao; Ren, He

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates

多表位TGFβ疫苗在胰腺癌治疗中的应用原理:来自免疫学和临床相关性的证据

Ruders, Josephine Hallundbæk; Ahmad, Shamaila Munir; Mortensen, Rasmus Erik Johansson; Met, Özcan; Byrdal, Mikkel; Chen, Inna Markovna; Theile, Susann; Holmström, Morten Orebo; Andersen, Mads Hald

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

胰腺癌:分子发病机制和新兴治疗策略

Rozengurt, Enrique; Eibl, Guido

Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer.

细胞外囊泡衍生的 miRNA-182-5p 可使胰腺癌中的巨噬细胞产生免疫抑制表型。

Singh Baldev, Gaur Pankaj, Bose Pritha, Zhang Yanjun, Li Yaoxiang, Zhang Zihao, Kandhavelu Jeyalakshmi, Klotzbier William, Jayatilake Meth, Bansal Shivani, Farhan Mohd, Deol Sunain, Banerjee Partha P, Unger Keith, Gupta Seema, Verma Vivek, Cheema Amrita K

Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations.

胰腺癌中垂直 RAS 通路抑制可驱动线粒体发生具有治疗意义的改变。

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial

自体多抗原靶向T细胞疗法治疗胰腺癌:一项1/2期试验

Musher, Benjamin L; Vasileiou, Spyridoula; Smaglo, Brandon G; Robertson, Catherine S; Wu, Mengfen; Wang, Tao; Watanabe, Ayumi; Kuvalekar, Manik; Velazquez, Yovana; Ketkar, Shamika; Doheyan, Tamadar Al; Papayanni, Penelope G; Shah, Aakash; Lapteva, Natalia; Grilley, Bambi J; Van Buren, George; Lulla, Premal D; Heslop, Helen E; Rooney, Cliona M; Brenner, Malcolm K; Leen, Ann M

NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.

NSD2抑制剂通过重塑染色质来治疗肺癌和胰腺癌。